跳至主要内容
临床试验/NCT01467791
NCT01467791Unknown不适用

Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH)

University of Cincinnati1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2011年11月最近更新:
适应症

试验速览

阶段
不适用
入组人数
300
试验地点
1
主要终点
Survival

研究概览

简要总结

Registry to follow patients with sarcoidosis associated pulmonary hypertension

详细描述

This is a multi center registry of sarcoidosis associated pulmonary hypertension (SAPH). With this registry, the investigators will characterize the demographics, clinical course, hemodynamics, pulmonary physiology, and disease management of sarcoidosis associated pulmonary hypertension on the United States. The investigators will also compare these features to non-US sites.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with sarcoidosis as defined by the ATS/WASOG statement
  • Patients with pulmonary hypertension as confirmed by right heart catheterization
  • Patients willing to provide written informed consent

排除标准

  • Unwillingness to provide assurance that they will complete the follow up visits for the study

结局指标

主要结局

Survival

时间窗: 4 years

Mortality during time of study

次要结局

  • Disease management(4 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Robert P Baughman

Professor of Medicine

University of Cincinnati

研究点 (1)

Loading locations...

相似试验